Study sheds light on how coronavirus may hijack human cells
PTI, Feb 13, 2021, 1:03 PM IST
Credit: iStock Photo
Berlin: Scientists, including one of Indian-origin, have identified parts of human proteins which the novel coronavirus could be using to hijack host cell processes, an advance that may lead to the development of new drugs for treating COVID-19.
The researchers, including Manjeet Kumar from the European Molecular Biology Laboratory (EMBL) in Germany, analysed the chain of amino acid molecules that makes up the human proteins involved in the coronavirus infection, such as a class of proteins called integrins.
Previous research had found that the SARS-CoV-2 virus that causes COVID-19, enters cells through a process called endocytosis upon binding to the cell surface receptor ACE2 and potentially other proteins like integrins.
In the current study, published in the journal Science Signalling, the scientists focussed particularly on short strings of amino acids called short linear motifs (SLiMs), which are involved in transmitting information between the inside and outside of cells.
They saw that several integrins contain SLiMs that are likely involved in the cellular processes of uptake and disposal of substances called endocytosis and autophagy.
“If SARS-CoV-2 targets proteins involved in endocytosis and autophagy, it means these processes might be hijacked by the virus during infection,” said Balint Meszaros, a co-author of the study from EMBL.
The researchers believe the findings may lead to new therapeutic approaches for COVID-19.
“SLiMs could ‘switch’ to turn viral entry signals on or off. This means that if we can find a way to reverse these switches using drugs, this might stop coronavirus from entering cells,” explained study senior author Lucia Chemes.
“Together, these findings have identified a potential link between autophagy and integrin signaling and could lead to new ways to prevent viral infection,” the scientists wrote in the study.
Based on the results, the researchers gathered a list of existing drugs that interfere with endocytosis and autophagy.
“If clinical trials prove some of these drugs to work against COVID-19, this could be a game changer,” Kumar added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
India successfully test-fires long-range cruise missile
IISc scientists develop enzyme-based solution to break antibiotic-resistant biofilms
Elon Musk’s Starlink yet to comply with security norms for satcom licence: Scindia
IN-SPACe introduces Model Rocketry Workshop to inspire young innovators
Don’t trust caller ID info; can be spoofed easily: Cyber advisory to govt officials
MUST WATCH
Latest Additions
Mangaluru: Lecturer succumbs to food allergy; Organs donated
Byelections: 81.84 per cent voter turnout in bypolls in three Assembly segments in Karnataka
Karnataka sets up panel for internal reservation among STs
Maharashtra Assembly Elections 2024 | Congress in clutches of urban naxals, became puppet of people with divisive agenda: J P Nadda
Even if Indira Gandhi returns from heaven, Article 370 will not be restored: Amit Shah
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.